#PDL1Inhibitor
LightNews LightNews
pharmaphorum.bsky.social
#AstraZeneca could be just months away from #FDA approval of a new #bladdercancer indication for its #PDL1inhibitor #Imfinzi, which is viewed as key to meeting its sales ambitions for the drug.

pharmaphorum.com/news/fda-sta...
September 25, 2026 at 12:07 PM
4040rec.bsky.social
#NICE #NICErecommedation #NHS #HEOR #AstraZeneca #Imfinzi #durvalumab #gastriccancer #Oncology #MSD #Winrevair #sotatercept #pulmonaryarterialhypertension #PAH #immunotherapy #PDL1inhibitor #GEJcancer #MATTERHORNtrial #StomachCancerUK #PAHtherapy #pulmonaryhypertension #PHAUK
zurl.co/iBqfl
NICE backs stomach cancer, PAH drugs for NHS use
AZ's Imfinzi is the first NHS immunotherapy for a form of stomach cancer, while MSD's Winrevair gets a green light for rare respiratory disease PAH.
pharmaphorum.com
May 19, 2026 at 2:13 PM
kstrategyand.bsky.social
www.linkedin.com/pulse/fda-ap...

FDA Approves UNLOXCYT™ from Checkpoint Therapeutics for Advanced Skin Cancer Treatment

kstrategyand.com/pharma-news

#CheckpointTherapeutics #UNLOXCYT #FDAApproval #Immunotherapy #SkinCancer #CutaneousSquamousCellCarcinoma #PDL1Inhibitor #Humanteconomy #Humantec
FDA Approves UNLOXCYT™ from Checkpoint Therapeutics for Advanced Skin Cancer Treatment
Checkpoint Therapeutics, Inc. has officially announced a groundbreaking achievement with the U.
www.linkedin.com
January 9, 2025 at 10:22 AM